Back to search

Article

De Novo Mutational Signature Discovery in Tumor Genomes using SparseSignatures

2018-08-04

Abstract excerpt

Cancer is the result of mutagenic processes that can be inferred from tumor genomes by analyzing rate spectra of point mutations, or “mutational signatures”. Here we present SparseSignatures, a novel framework to extract signatures from somatic point mutation data. Our approach incorporates a user-specified background signature, employs regularization to reduce noise in non-background signatures, uses cross-valida...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
488862fd-94a2-5748-b442-88cd41fc7197
DOI
10.1101/384834
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
De Novo Mutational Signature Discovery in Tumor Genomes using SparseSignaturesDOI 10.1101/384834
Select a neighboring publication to make it the new centre.